IBDEI11T ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17802,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,17802,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,17803,0)
 ;;=N76.0^^76^858^243
 ;;^UTILITY(U,$J,358.3,17803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17803,1,3,0)
 ;;=3^Vaginitis, Unspecified cause, acute
 ;;^UTILITY(U,$J,358.3,17803,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,17803,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,17804,0)
 ;;=N76.2^^76^858^16
 ;;^UTILITY(U,$J,358.3,17804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17804,1,3,0)
 ;;=3^Acute vulvitis
 ;;^UTILITY(U,$J,358.3,17804,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,17804,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,17805,0)
 ;;=N76.3^^76^858^226
 ;;^UTILITY(U,$J,358.3,17805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17805,1,3,0)
 ;;=3^Subacute and chronic vulvitis
 ;;^UTILITY(U,$J,358.3,17805,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,17805,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,17806,0)
 ;;=N76.1^^76^858^225
 ;;^UTILITY(U,$J,358.3,17806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17806,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,17806,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,17806,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,17807,0)
 ;;=B97.89^^76^858^244
 ;;^UTILITY(U,$J,358.3,17807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17807,1,3,0)
 ;;=3^Viral syndrome
 ;;^UTILITY(U,$J,358.3,17807,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,17807,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,17808,0)
 ;;=Z77.21^^76^858^84
 ;;^UTILITY(U,$J,358.3,17808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17808,1,3,0)
 ;;=3^Exposure to potentially hazardous bodily fluids
 ;;^UTILITY(U,$J,358.3,17808,1,4,0)
 ;;=4^Z77.21
 ;;^UTILITY(U,$J,358.3,17808,2)
 ;;=^5063323
 ;;^UTILITY(U,$J,358.3,17809,0)
 ;;=Z72.51^^76^858^120
 ;;^UTILITY(U,$J,358.3,17809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17809,1,3,0)
 ;;=3^High Risk Sexual Behaviors
 ;;^UTILITY(U,$J,358.3,17809,1,4,0)
 ;;=4^Z72.51
 ;;^UTILITY(U,$J,358.3,17809,2)
 ;;=^5063258
 ;;^UTILITY(U,$J,358.3,17810,0)
 ;;=Z20.828^^76^858^47
 ;;^UTILITY(U,$J,358.3,17810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17810,1,3,0)
 ;;=3^Contact or exposure to other viral diseases
 ;;^UTILITY(U,$J,358.3,17810,1,4,0)
 ;;=4^Z20.828
 ;;^UTILITY(U,$J,358.3,17810,2)
 ;;=^5062774
 ;;^UTILITY(U,$J,358.3,17811,0)
 ;;=Z79.899^^76^858^146
 ;;^UTILITY(U,$J,358.3,17811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17811,1,3,0)
 ;;=3^Long term use of medications
 ;;^UTILITY(U,$J,358.3,17811,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,17811,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,17812,0)
 ;;=Z23.^^76^858^74
 ;;^UTILITY(U,$J,358.3,17812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17812,1,3,0)
 ;;=3^Encounter for immunization
 ;;^UTILITY(U,$J,358.3,17812,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,17812,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,17813,0)
 ;;=A08.4^^76^858^96
 ;;^UTILITY(U,$J,358.3,17813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17813,1,3,0)
 ;;=3^Gastroenteritis, viral
 ;;^UTILITY(U,$J,358.3,17813,1,4,0)
 ;;=4^A08.4
 ;;^UTILITY(U,$J,358.3,17813,2)
 ;;=^5000059
 ;;^UTILITY(U,$J,358.3,17814,0)
 ;;=B16.9^^76^858^105
 ;;^UTILITY(U,$J,358.3,17814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17814,1,3,0)
 ;;=3^Hepatitis B, acute
 ;;^UTILITY(U,$J,358.3,17814,1,4,0)
 ;;=4^B16.9
 ;;^UTILITY(U,$J,358.3,17814,2)
 ;;=^5000540
 ;;^UTILITY(U,$J,358.3,17815,0)
 ;;=B18.1^^76^858^106
 ;;^UTILITY(U,$J,358.3,17815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17815,1,3,0)
 ;;=3^Hepatitis B, chronic without coma
 ;;^UTILITY(U,$J,358.3,17815,1,4,0)
 ;;=4^B18.1
 ;;^UTILITY(U,$J,358.3,17815,2)
 ;;=^5000547
